GeneDx is trading 4.22% down at $73.06, with available evidence not establishing a definite cause.

  • The price was reported as of 10:17 a.m. ET on October 6, 2026.
  • Biotech ETF XBI was down 2.50%, while major U.S. indexes were higher.
  • No clear company-specific announcement appeared in the available search results; the latest company release was its October 2 announcement of the Easy Order workflow at the AAP conference.